Welcome Media

Thank you for your interest in Epoch—a randomized, placebo-controlled, parallel-group, double-blind efficacy and safety study for participants with mild to moderate Alzheimer’s disease (AD). The research team greatly appreciates your taking time to visit our site.

If you need additional information or would like to schedule an interview, please contact Caroline Lappetito at (267) 305-7639 or caroline_lappetito@merck.com.